Author:
Goyal Ramesh K.,Aggarwal Geeta
Publisher
Springer Nature Singapore
Reference46 articles.
1. Ananthamohan K, Jha RM, Sharma S (2019) Chapter 4 – Use of circulating nucleic acids, metabolites, and proteins as clinical biomarkers for earlier prognosis and diagnosis of disease. In: Prognostic epigenetics volume 15 in translational epigenetics. Academic Press, Oxford, pp 85–116. https://doi.org/10.1016/B978-0-12-814259-2.00005-4
2. Aronson JK, Ferner RE (2017) Biomarkers—a general review. Curr Protoc Pharmacol 76(1):9.23.1–9.23.17. https://doi.org/10.1002/cpph.19
3. Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673–683. https://doi.org/10.1038/nrd1468
4. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8(2):47–52
5. Campbell LL, Polyak K (2007) Breast tumor heterogeneity: cancer stem cells or clonal evolution. Cell Cycle 6:2332–2338. https://doi.org/10.4161/cc.6.19.4914. Epub 2007 Aug 17